131 related articles for article (PubMed ID: 7140679)
1. In vivo and in vitro genotoxicity of three antihypertensive hydrazine derivatives (hydralazine, dihydralazine, and endralazine).
de Flora S; Zanacchi P; Bennicelli C; Camoirano A; Cavanna M; Sciabà L; Cajelli E; Faggin P; Brambilla G
Environ Mutagen; 1982; 4(5):605-19. PubMed ID: 7140679
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity of the antihypertensive drugs hydralazine and dihydralazine.
Williams GM; Mazue G; McQueen CA; Shimada T
Science; 1980 Oct; 210(4467):329-30. PubMed ID: 7423193
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mutagenic activity of hydralazine and dihydralazine in Salmonella typhimurium strains differing in expression of antioxidant genes.
Chłopkiewicz B
Toxicol Lett; 1999 Nov; 110(3):203-7. PubMed ID: 10597029
[TBL] [Abstract][Full Text] [Related]
4. Influence of metabolic activation on the induction of micronuclei by antihypertensive drugs in L929 cells.
Chłopkiewicz B
Arch Toxicol; 2001 Feb; 74(12):794-8. PubMed ID: 11305783
[TBL] [Abstract][Full Text] [Related]
5. Genotoxic activity of five antidepressant hydrazines in a battery of in vivo and in vitro short-term tests.
Brambilla G; Cavanna M; Faggin P; Pino A; Robbiano L; Bennicelli C; Zanacchi P; Camoirano A; De Flora S
J Toxicol Environ Health; 1982 Feb; 9(2):287-303. PubMed ID: 7042990
[TBL] [Abstract][Full Text] [Related]
6. Assay of phenacetin genotoxicity using in vitro and in vivo test systems.
De Flora S; Russo P; Pala M; Fassina G; Zunino A; Bennicelli C; Zanacchi P; Camoirano A; Parodi S
J Toxicol Environ Health; 1985; 16(3-4):355-77. PubMed ID: 3910846
[TBL] [Abstract][Full Text] [Related]
7. Genotoxicity of hydrazino-phtalazine antihypertensive drugs assessed by an in vitro micronucleus assay.
Chłopkiewicz B
Acta Pol Pharm; 1996; 53(5):361-4. PubMed ID: 9415211
[TBL] [Abstract][Full Text] [Related]
8. Propyldazine is mutagenic in Salmonella typhimurium and Escherichia coli: distinct specificity for strains TA1537 and TA97.
Glatt H; Oesch F
Teratog Carcinog Mutagen; 1985; 5(5):339-45. PubMed ID: 2867616
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of the arteriolar vasodilators hydralazine, dihydralazine and endralazine in the conscious spontaneously hypertensive rat.
Struyker-Boudier HA; van Essen H; Smits JF
Eur J Pharmacol; 1983 Nov; 95(3-4):151-9. PubMed ID: 6653667
[TBL] [Abstract][Full Text] [Related]
10. Genetic toxicity of several antihypertensive drugs possessing a hydrazine group.
Kitamura J; Mori H; Sugie S; Kawai K
Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):415-22. PubMed ID: 4059657
[TBL] [Abstract][Full Text] [Related]
11. Genotoxic activity and potency of 135 compounds in the Ames reversion test and in a bacterial DNA-repair test.
De Flora S; Zanacchi P; Camoirano A; Bennicelli C; Badolati GS
Mutat Res; 1984 May; 133(3):161-98. PubMed ID: 6374443
[TBL] [Abstract][Full Text] [Related]
12. Endralazine, a new peripheral vasodilator--a randomized cross-over trial against dihydralazine.
Kirch W; Axthelm T
J Cardiovasc Pharmacol; 1982; 4(4):562-6. PubMed ID: 6181329
[TBL] [Abstract][Full Text] [Related]
13. DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity.
Parodi S; De Flora S; Cavanna M; Pino A; Robbiano L; Bennicelli C; Brambilla G
Cancer Res; 1981 Apr; 41(4):1469-82. PubMed ID: 7214329
[TBL] [Abstract][Full Text] [Related]
14. Studies on the mechanism of mutagenicity and genotoxicity induced by dihydralazine.
Chłopkiewicz B; Ejchart A; Marczewska J
Acta Biochim Pol; 1995; 42(3):291-5. PubMed ID: 8588478
[TBL] [Abstract][Full Text] [Related]
15. Studies on the mechanism of hydralazine induced mutagenicity and genotoxicity.
Chopkiewicz B; Ejchart A; Marczewska J
Acta Pol Pharm; 1995; 52(3):219-22. PubMed ID: 8960252
[TBL] [Abstract][Full Text] [Related]
16. Genetic effects of binazine and hydralazine in vitro and in vivo.
Chłopkiewicz B; Ejchart A; Marczewska J
Acta Pol Pharm; 1995; 52(1):31-3. PubMed ID: 8960236
[TBL] [Abstract][Full Text] [Related]
17. Genotoxicity assay of oil dispersants in bacteria (mutation, differential lethality, SOS DNA-repair) and yeast (mitotic crossing-over).
De Flora S; De Renzi GP; Camoirano A; Astengo M; Basso C; Zanacchi P; Bennicelli C
Mutat Res; 1985; 158(1-2):19-30. PubMed ID: 3900716
[TBL] [Abstract][Full Text] [Related]
18. Studies in the rat on endralazine, a new antihypertensive drug structurally related to hydralazine.
Oates HF; Stoker LM
Clin Exp Pharmacol Physiol; 1981; 8(2):133-9. PubMed ID: 7018762
[TBL] [Abstract][Full Text] [Related]
19. Testing of hydralazine in in vivo-in vitro hepatocyte assays for UDS and stimulation of replicative DNA synthesis.
Puri EC; Müller D
Mutat Res; 1989 Jul; 218(1):13-9. PubMed ID: 2747710
[TBL] [Abstract][Full Text] [Related]
20. Toxicology and carcinogenesis studies of methylene blue trihydrate (Cas No. 7220-79-3) in F344/N rats and B6C3F1 mice (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2008 May; (540):1-224. PubMed ID: 18685714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
